"India's public health spending gap and private sector regulation remain unresolved"
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortisation; a financial performance metric used by PE-backed hospitals.
ARPOB
Average Revenue Per Occupied Bed; a hospital financial metric prioritising revenue over patient outcomes.
India's public health financing has long been characterised by chronic under-investment relative to both its own policy targets and international benchmarks. The National Health Policy (NHP) 2017 set an aspirational target of raising government health expenditure to 2.5% of GDP — a figure that has since become the central reference point in every major health policy debate. Yet India's actual government health spend has hovered stubbornly in the 1.4% of GDP range, making the gap between aspiration and reality one of the most persistent structural failures in Indian social policy. Total health expenditure (public plus private) stands at approximately 3.2–3.4% of GDP, meaning the private sector accounts for the overwhelming majority of healthcare delivery in the country.
The constitutional backdrop is important: the Supreme Court has interpreted Article 21 (right to life) to include the right to health, creating a justiciable obligation on the state. Simultaneously, health is a State subject under the Seventh Schedule, which has historically allowed the Union government to deflect regulatory responsibility to states — a tension that continues to play out in ongoing litigation. The Clinical Establishments (Registration and Regulation) Act, 2010, enacted with rules framed in 2012, was the Union's primary legislative attempt to bring private healthcare under a regulatory framework, but its implementation has remained deeply uneven.
The structural problem in Indian healthcare financing is a self-reinforcing cycle: inadequate public investment creates gaps in service delivery, which the private sector fills, and the private sector — increasingly driven by private equity (PE) capital — operates on financial metrics rather than public health outcomes. Terms like EBITDA (earnings before interest, taxes, depreciation, and amortisation) and ARPOB (average revenue per occupied bed) have become the operative vocabulary of hospital boardrooms, displacing patient-outcome metrics. PE investors typically seek quick exits to capitalise on returns, which structurally incentivises cost extraction from patients rather than long-term investment in care quality.
The Clinical Establishments Act, 2010 was designed to address precisely this regulatory vacuum. Its statement of objects and reasons explicitly identified problems of inadequate treatment, excessive use of high-cost technologies, and medical malpractice in the unregulated private sector. …
A decrease in tax to GDP ratio of a country indicates which of the following?
1.Slowing economic growth rate
2.Less equitable distribution of national income
Select the correct answer using the code given below.
Increase in absolute and per capita real GNP do not connote a higher level of economic development, if
Consider the following statements regarding India's public health expenditure:
1.The National Health Policy 2017 targets government health expenditure at 2.5% of GDP.
2.India's actual government health expenditure is currently above 2% of GDP.
3.India's total health expenditure (public and private combined) is approximately 3.2–3.4% of GDP.
Which of the statements given above is/are correct?
Which of the following best describes the constitutional basis for the Supreme Court's jurisdiction over the right to health in India?
With reference to the Clinical Establishments (Registration and Regulation) Act, 2010, consider the following statements:
1.The Act applies automatically to all states upon enactment by Parliament.
2.The Act was enacted to address the largely unregulated nature of private sector healthcare delivery in India.
3.Rules under the Act were framed in 2012.
Which of the statements given above is/are correct?
The term 'ARPOB', sometimes seen in discussions on private healthcare in India, refers to:
Assertion (A): India's Pradhan Mantri Jan Arogya Yojana has not yet achieved transformative scale in reducing out-of-pocket healthcare expenditure.
Reason (R): Private hospitals have shown reluctance to empanel under the scheme, partly due to large pending dues under government health reimbursement programmes.
Which of the following is correct?
Want the full note, Prelims Facts & MCQ answers?
Create a free account — takes less than a minute.
Create free account